Horizon Kinetics Asset Management »

Regeneron Pharmaceuticals shares owned by Horizon Kinetics Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Horizon Kinetics Asset Management from 13F filings

Historical chart of Horizon Kinetics Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Horizon Kinetics Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Horizon Kinetics Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $646k 735 878.29
2023-09-30 $630k 765 822.96
2023-06-30 $550k 765 718.54
2023-03-31 $629k 765 821.67

More positions owned by Horizon Kinetics Asset Management

Texas Pacific Land Corp (TPL)
Grayscale Bitcoin Trust Btc Trust Btc (GBTC)
Wheaton Precious Metals Corp (WPM)
Caci Intl Inc Cl A Cl A (CACI)
Intercontinental Exchange (ICE)
Franco-Nevada Corporation (FNV)
Civeo Corp Com New (CVEO)
Cheniere Energy Com New (Principal) (LNG)
CBOE Holdings (CBOE)
Mesabi Tr Ctf Ben Int (MSB)
Science App Int'l (SAIC)
Brookfield Corp Cl A Lmt Vtg S Cl A Ltd Vt Sh (BN)
Permian Basin Rty Tr Unit Ben Int (PBT)
Archer Daniels Midland Company (ADM)
Howard Hughes Holdings (HHH)

View all positions for Horizon Kinetics Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals